Brind.

Bio company DQS is involved in the Prospera Heart test, while Natera presented data at WTC in San Francisco.

1 report, 1 independent Updated Aug 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

DQS San Francisco Natera

Keep exploring

The entities involved

DQS
company

Nothing else this week.
San Francisco
consolidated city and county in California, United States
- Lee Jae Myung met with a community in San Francisco and stated his goal to improve voting access in China.Mon 09:38
- Mayor Daniel Lurie and the Board of Supervisors discussed economic impact and public safety improvements in San Francisco.Sun 23:52
Natera
company in San Carlos, United States
- Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.Mon 02:47
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44

Coverage

Newest first; wire copies grouped

Aug 1Business WireNatera Highlights Latest Prospera™ Data at WTC 2025; 16 Abstracts Including Five Oral Presentations High-impact datasets across heart, kidney and lung at WTC follows two major publications in the Ame